Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1453.1000 57.10 (4.09%)
NSE Nov 28, 2025 15:50 PM
Volume: 454.5K
 

1453.10
4.09%
Prabhudas Lilladhar
Q4FY22/Q1FY23. Domestic business (45% of total sales) continues to remain on strong footing and should continue to outperform IPM. Strong API capabilities and diversified model benefit IPCA in the current environment. We recommend Buy' rating on the stock with target price of Rs 2,450 based...
ICICI Direct upgraded Ipca Laboratories Ltd. to Buy with a price target of 1660.0 on 17 Nov, 2025.
More from Ipca Laboratories Ltd.
Recommended